Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group

BACKGROUND: Current treatment guidelines recommend adjuvant mitotane after resection of adrenocortical carcinoma with high-risk features (eg, tumor rupture, positive margins, positive lymph nodes, high grade, elevated mitotic index, and advanced stage). Limited data exist on the outcomes associated...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Am Coll Surg
Hoofdauteurs: Postlewait, Lauren M, Ethun, Cecilia G, Tran, Thuy B, Prescott, Jason D, Pawlik, Timothy M, Wang, Tracy S, Glenn, Jason, Hatzaras, Ioannis, Shenoy, Rivfka, Phay, John E, Keplinger, Kara, Fields, Ryan C, Jin, Linda X, Weber, Sharon M, Salem, Ahmed, Sicklick, Jason K, Gad, Shady, Yopp, Adam C, Mansour, John C, Duh, Quan-Yang, Seiser, Natalie, Solorzano, Carmen C, Kiernan, Colleen M, Votanopoulos, Konstantinos I, Levine, Edward A, Staley, Charles A, Poultsides, George A, Maithel, Shishir K
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2015
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957938/
https://ncbi.nlm.nih.gov/pubmed/26775162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jamcollsurg.2015.12.013
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items